Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
UBS
Covington
Cerilliant
Boehringer Ingelheim
Healthtrust
Queensland Health
Dow
Chubb

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205975

« Back to Dashboard

NDA 205975 describes NAFTIFINE HYDROCHLORIDE, which is a drug marketed by Taro and Tolmar and is included in three NDAs. It is available from two suppliers. Additional details are available on the NAFTIFINE HYDROCHLORIDE profile page.

The generic ingredient in NAFTIFINE HYDROCHLORIDE is naftifine hydrochloride. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the naftifine hydrochloride profile page.
Summary for 205975
Tradename:NAFTIFINE HYDROCHLORIDE
Applicant:Taro
Ingredient:naftifine hydrochloride
Patents:0
Therapeutic Class:Antifungals
Pharmacology for NDA: 205975
Ingredient-typeAllylamine
Suppliers and Packaging for NDA: 205975
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NAFTIFINE HYDROCHLORIDE naftifine hydrochloride CREAM;TOPICAL 205975 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1362 N 51672-1362-1
NAFTIFINE HYDROCHLORIDE naftifine hydrochloride CREAM;TOPICAL 205975 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1362 N 51672-1362-2

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength1%
Approval Date:Sep 8, 2016TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Baxter
QuintilesIMS
Express Scripts
Cerilliant
Daiichi Sankyo
US Department of Justice
Queensland Health
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.